Circassia pays $32M for rights to AirNOvent by Anna Smith | Jan 25, 2019 | News | 0 UK group Circassia has announced plans to acquire US and Chinese commercialisation rights to AirNOvent, a novel nitric oxide product, from AIT Therapeutics. Read More